JP Morgan and Houlihan Lokey have led the mergers and acquisitions (M&A) rankings for financial advisers in the first half of ...

Can this ASX 200 juggernaut go higher? The post JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in ...

Because they touch so many parts of this economy, banks’ quarterly reports can reveal a lot.

JPMorgan Chase will give investors a view into how U.S. consumers and corporations fared in the second quarter.

Europe is “losing” the fight for economic supremacy against its main rivals China and the US, and faces a drought of globally ...

On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...

Here are four stocks from the J.P. Morgan's Analyst Focus List for cautious investors consider for the second half of 2025.

Molina Healthcare, Inc. (NYSE:MOH) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 7, JP Morgan ...

Fields West, an under-development mixed-use development in Frisco, Texas, announced the closing of a $425 million ...

Investing.com -- JP Morgan initiated coverage of Circle with an Underweight rating and a price target of $80, arguing the ...

On 7 July, JP Morgan initiated coverage of Guzman Y Gomez shares. This marks the first time the broker has analysed the ...